| dc.contributor.author | Laura Ordovás | |
| dc.contributor.author | Ruben Boon | |
| dc.contributor.author | Mariaelena Pistoni | |
| dc.contributor.author | Yemiao Chen | |
| dc.contributor.author | Esther Wolfs | |
| dc.contributor.author | Wenting Guo | |
| dc.contributor.author | Rangarajan Sambathkumar | |
| dc.contributor.author | Sylwia Bobis-Wozowicz | |
| dc.contributor.author | Nicky Helsen | |
| dc.contributor.author | Jolien Vanhove | |
| dc.contributor.author | Pieter Berckmans | |
| dc.contributor.author | Qing Cai | |
| dc.contributor.author | Kim Vanuytsel | |
| dc.contributor.author | Kristel Eggermont | |
| dc.contributor.author | Veerle Vanslembrouck | |
| dc.contributor.author | Béla Z. Schmidt | |
| dc.contributor.author | Susanna Raitano | |
| dc.contributor.author | Ludo Van Den Bosch | |
| dc.contributor.author | Yaakov Nahmias | |
| dc.contributor.author | Toni Cathomen | |
| dc.contributor.author | Tom Struys | |
| dc.contributor.author | Catherine M. Verfaillie | |
| dc.contributor.other | Stem Cell Institute, KU Leuven, Leuven 3000, Belgium | |
| dc.contributor.other | Stem Cell Institute, KU Leuven, Leuven 3000, Belgium | |
| dc.contributor.other | Stem Cell Institute, KU Leuven, Leuven 3000, Belgium | |
| dc.contributor.other | Stem Cell Institute, KU Leuven, Leuven 3000, Belgium | |
| dc.contributor.other | Group of Morphology, Biomedical Research Institute, Hasselt University, Diepenbeek 3590, Belgium | |
| dc.contributor.other | Leuven Research Institute for Neuroscience and Disease (LIND), Leuven 3000, Belgium | |
| dc.contributor.other | Stem Cell Institute, KU Leuven, Leuven 3000, Belgium | |
| dc.contributor.other | Institute for Cell and Gene Therapy, University Medical Center Freiburg, Freiburg 79108, Germany | |
| dc.contributor.other | Stem Cell Institute, KU Leuven, Leuven 3000, Belgium | |
| dc.contributor.other | Stem Cell Institute, KU Leuven, Leuven 3000, Belgium | |
| dc.contributor.other | Stem Cell Institute, KU Leuven, Leuven 3000, Belgium | |
| dc.contributor.other | Stem Cell Institute, KU Leuven, Leuven 3000, Belgium | |
| dc.contributor.other | Stem Cell Institute, KU Leuven, Leuven 3000, Belgium | |
| dc.contributor.other | Stem Cell Institute, KU Leuven, Leuven 3000, Belgium | |
| dc.contributor.other | Stem Cell Institute, KU Leuven, Leuven 3000, Belgium | |
| dc.contributor.other | Switch Laboratory, VIB, Leuven 3000, Belgium | |
| dc.contributor.other | Stem Cell Institute, KU Leuven, Leuven 3000, Belgium | |
| dc.contributor.other | Leuven Research Institute for Neuroscience and Disease (LIND), Leuven 3000, Belgium | |
| dc.contributor.other | Department of Cell and Developmental Biology, Hebrew University of Jerusalem, Jerusalem 91904, Israel | |
| dc.contributor.other | Institute for Cell and Gene Therapy, University Medical Center Freiburg, Freiburg 79108, Germany | |
| dc.contributor.other | Group of Morphology, Biomedical Research Institute, Hasselt University, Diepenbeek 3590, Belgium | |
| dc.contributor.other | Stem Cell Institute, KU Leuven, Leuven 3000, Belgium | |
| dc.date.accessioned | 2015-11-12T05:00:39Z | |
| dc.date.available | 2025-10-02T03:44:57Z | |
| dc.date.issued | 01-11-2015 | |
| dc.identifier.issn | - | |
| dc.identifier.uri | http://www.sciencedirect.com/science/article/pii/S2213671115002660 | |
| dc.description.abstract | Tools for rapid and efficient transgenesis in “safe harbor” loci in an isogenic context remain important to exploit the possibilities of human pluripotent stem cells (hPSCs). We created hPSC master cell lines suitable for FLPe recombinase-mediated cassette exchange (RMCE) in the AAVS1 locus that allow generation of transgenic lines within 15 days with 100% efficiency and without random integrations. Using RMCE, we successfully incorporated several transgenes useful for lineage identification, cell toxicity studies, and gene overexpression to study the hepatocyte lineage. However, we observed unexpected and variable transgene expression inhibition in vitro, due to DNA methylation and other unknown mechanisms, both in undifferentiated hESC and differentiating hepatocytes. Therefore, the AAVS1 locus cannot be considered a universally safe harbor locus for reliable transgene expression in vitro, and using it for transgenesis in hPSC will require careful assessment of the function of individual transgenes. | |
| dc.format | - | |
| dc.language.iso | EN | |
| dc.publisher | Elsevier | |
| dc.relation.uri | ['https://wajhn.com/index.php/journal/editorial-policy', 'https://wajhn.com/index.php/journal/open-access-policy', 'https://wajhn.com/index.php/journal/index', 'https://wajhn.com/index.php/journal/aim-scope'] | |
| dc.rights | CC BY | |
| dc.subject | ['health', 'medicine', 'public health', 'nutrition', 'health sciences', 'medical sciences', 'Nutritional diseases. Deficiency diseases', 'RC620-627'] | |
| dc.subject.lcc | Medicine (General) | |
| dc.title | Efficient Recombinase-Mediated Cassette Exchange in hPSCs to Study the Hepatocyte Lineage Reveals AAVS1 Locus-Mediated Transgene Inhibition | |
| dc.type | Article | |
| dc.description.pages | 918-931 | |
| dc.description.doi | 10.1016/j.stemcr.2015.09.004 | |
| dc.title.journal | Stem Cell Reports | |
| dc.identifier.e-issn | - | |
| dc.identifier.oai | oai:doaj.org/journal:104293e2640a470085393893e506221e | |
| dc.journal.info | Volume 5, Issue 5 | |